4th Annual RNA-Targeted Drug Discovery Summit - Digital Event - EST
Evvnt Promotion / evvnt
Archivo
07.12.2021 - 09.12.2021 Online
Time: 8:30 am - 5:00 pm
Temas de la conferencia
As the first small-molecule drug targeting RNA gains momentum, the ability to design small molecules capable of interacting with and modulating RNA is opening as a new avenue to target challenging disease pathways that have previously been considered undruggable.
As the first small-molecule drug targeting RNA gains momentum, the ability to design small molecules capable of interacting with and modulating RNA is opening as a new avenue to target challenging disease pathways that have previously been considered undruggable.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/851095-3?pid=4832
Speakers: Hashim Al-Hashimi, Professor, Duke University, Matthew Disney, Professor, Scripps Research, Jennifer Petter, Founder and Chief Innovation Officer, Arrakis Therapeutics and more
Brochure: https://go.evvnt.com/851095-3?pid=4832
Speakers: Hashim Al-Hashimi, Professor, Duke University, Matthew Disney, Professor, Scripps Research, Jennifer Petter, Founder and Chief Innovation Officer, Arrakis Therapeutics and more
Información e inscripción:
https://go.evvnt.com/851095-2?pid=4832
Ms. Katie Jacobs
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
